Cyclerion Therapeutics lays off nearly half of workforce
Cyclerion Therapeutics Inc. is culling its workforce as it narrows its focus to mitochondrial diseases. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - October 7, 2022 Category: American Health Authors: Rowan Walrath Source Type: news
Arch, Google back $72.5M round for new mitochondria startup
With $72.5 million from investors including Arch Ventures and GV, a new startup is launching with a singular focus: mitochondrial diseases. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 12, 2022 Category: Pharmaceuticals Authors: Rowan Walrath Source Type: news
NIEHS researchers first to determine 3D structure of twinkle protein
<div class="rxbodyfield">Researchers hope discovery leads to potential treatments for mitochondrial diseases.</div> (read more) (Source: Environmental Factor - NIEHS Newsletter)
Source: Environmental Factor - NIEHS Newsletter - September 2, 2022 Category: Environmental Health Source Type: news
NIH first to develop 3D structure of twinkle protein
Researchers hope discovery leads to potential treatments for mitochondrial diseases. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - August 5, 2022 Category: American Health Source Type: news
NIH First to Develop 3D Structure of Twinkle Protein
Sparks new hope for patients with mitochondrial diseases. (Source: NIEHS News)
Source: NIEHS News - August 5, 2022 Category: Environmental Health Source Type: news
Toxic agents can target mitochondria, influence disease, expert says
<div class="rxbodyfield">Joel Meyer, Ph.D., discussed his research into how early-life mitochondrial toxicity can affect later-life health, during NIEHS lecture.</div> (read more) (Source: Environmental Factor - NIEHS Newsletter)
Source: Environmental Factor - NIEHS Newsletter - August 2, 2022 Category: Environmental Health Source Type: news
Can our mitochondria help to beat long Covid?
Mitochondria are the body ’s power plants, fuelling our cells. New research shows they play a role in many aspects of keeping us healthy – and could be the key to unlocking treatments for chronic diseases, including Parkinson’sAt Cambridge University ’s MRC Mitochondrial Biology Unit, Michal Minczuk is one of a growing number of scientists around the world aiming to find new ways of improving mitochondrial health. This line of research could help provide much-needed treatments for people with long Covid, as well as revolutionising our understa nding of everything from neurodegenerative illnesses such as Parkinson...
Source: Guardian Unlimited Science - June 26, 2022 Category: Science Authors: David Cox Tags: Medical research Biology Long Covid Coronavirus Infectious diseases Genetics Society Science Microbiology Source Type: news
Peter Kay: Comic's 'first hand experience' of 'complex' disease - condition explained
SIX YEARS after stepping away from the public eye, sources have hinted that comedian Peter Kay will head back out on a mammoth tour in 2023. Since cancelling his 14-month tour back in 2017 due to "unforeseen family circumstances," Kay, 48, has only made brief appearances at public events. One of these was at an event run by The Lily Foundation, which helps children with mitochondrial disease, which he said he has "first-hand experience" of. (Source: Daily Express - Health)
Source: Daily Express - Health - May 26, 2022 Category: Consumer Health News Source Type: news
To fight diseases of aging, scientist makes aging itself the target
When Dr. Ming Guo says that she wants to reverse the aging process, she ’s not outlining a fantastical quest for the Fountain of Youth. She’s looking for ways to defeat incurable diseases.“If we could pause, delay or even reverse aging, we would make a significant impact against numerous diseases,” said Guo, professor of neurology, molecular and medical pharmacology at theDavid Geffen School of Medicine at UCLA.“I want to create a higher quality of life over a healthy life span, rather than just prolonging life.”Her particular approach to her research is inspired by her compassion for her patients who have Alzh...
Source: UCLA Newsroom: Health Sciences - March 24, 2022 Category: Universities & Medical Training Source Type: news
Researchers show protein controls process that goes awry in Parkinson ’s disease
As scientists work toward finding a cure for Parkinson ’s disease, one line of research that has emerged focuses on mitochondria, the structures within cells that make energy. The health of those structures is maintained through a quality control system that balances two opposite processes: fission — one mitochondrion splitting in two — and fusion — two becoming one.When there ’s a problem with fission, that system is thrown out of balance. The consequences can include neurodegenerative diseases, such as Parkinson’s disease, and other serious conditions.For years, scientists have known that one particular prote...
Source: UCLA Newsroom: Health Sciences - March 24, 2022 Category: Universities & Medical Training Source Type: news
Sharing Mayo Clinic: How the right diagnosis and a new approach changed my life
Editor's note: This story was written by Lauren Quinn, who had been diagnosed with mitochondrial disease as a teenager before coming to Mayo Clinic for care. I've always been an active girl. Running cross-country, playing lacrosse and dribbling down the basketball court is where I shined. But in 2008, my life was turned upside down, and it would be 13 years before things would get better. I vividly remember a family vacation when I started… (Source: Mayo Clinic Florida News)
Source: Mayo Clinic Florida News - February 6, 2022 Category: Hospital Management Source Type: news
TK2d Patient Voices Elevated at FDA; United Mitochondrial Disease...
In a historic first, the Food and Drug Administration (FDA) held a listening session regarding Thymidine kinase 2 deficiency (TK2d), a rare mitochondrial disease and enzyme deficiency. The Jan. 31,...(PRWeb February 04, 2022)Read the full story at https://www.prweb.com/releases/2022/02/prweb18473220.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 4, 2022 Category: Pharmaceuticals Source Type: news
Mitochondrial damage likely a cause, not a consequence, of Parkinson ’s
<div class="rxbodyfield">During his NIEHS Distinguished Lecture, D. James Surmeier presented evidence that could resolve a longstanding debate about the disease.</div> (read more) (Source: Environmental Factor - NIEHS Newsletter)
Source: Environmental Factor - NIEHS Newsletter - December 2, 2021 Category: Environmental Health Source Type: news
Sex differences in mitochondrial function following a controlled cortical impact traumatic brain injury in rodents - Kalimon OJ, Sullivan PG.
Traumatic brain injury (TBI) is a complex disease to study due to the multifactorial injury cascades occurring after the initial blow to the head. One of the most vital players in this secondary injury cascade, and therapeutic target of interest, is the mi... (Source: SafetyLit)
Source: SafetyLit - November 3, 2021 Category: International Medicine & Public Health Tags: TBI Source Type: news
New Options Explored for Sarcopenia in Rheumatic Diseases New Options Explored for Sarcopenia in Rheumatic Diseases
Targeting mitochondrial pathways has produced the most promising results so far, but other avenues are being explored as well, experts said.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - August 18, 2021 Category: Drugs & Pharmacology Tags: Rheumatology News Source Type: news
